Nationwide Fund Advisors’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-32,008
Closed -$378K 3000
2017
Q3
$378K Buy
32,008
+18,400
+135% +$206K ﹤0.01% 2319
2017
Q2
$143K Sell
13,608
-43,300
-76% -$441K ﹤0.01% 2762
2017
Q1
$626K Sell
56,908
-10,357
-15% -$120K ﹤0.01% 2037
2016
Q4
$911K Buy
67,265
+51,621
+330% +$720K ﹤0.01% 1839
2016
Q3
$193K Hold
15,644
﹤0.01% 2641
2016
Q2
$172K Hold
15,644
﹤0.01% 2686
2016
Q1
$171K Sell
15,644
-755
-5% -$9.54K ﹤0.01% 2608
2015
Q4
$284K Buy
16,399
+275
+2% +$4.93K ﹤0.01% 2381
2015
Q3
$320K Hold
16,124
﹤0.01% 2347
2015
Q2
$265K Buy
16,124
+3,078
+24% +$53.4K ﹤0.01% 2563
2015
Q1
$203K Sell
13,046
-87,968
-87% -$1.36M ﹤0.01% 2686
2014
Q4
$1.44M Sell
101,014
-56,900
-36% -$601K 0.01% 1601
2014
Q3
$1.03M Buy
157,914
+331
+0.2% +$2.2K ﹤0.01% 1820
2014
Q2
$1.09M Sell
157,583
-7,296
-4% -$51.6K ﹤0.01% 1812
2014
Q1
$1.18M Buy
164,879
+122,837
+292% +$1.05M 0.01% 1642
2013
Q4
$395K Buy
42,042
+31,117
+285% +$222K ﹤0.01% 2350
2013
Q3
$68K Buy
10,925
+1,638
+18% +$10.2K ﹤0.01% 3018
2013
Q2
$61K Buy
+9,287
New +$73.7K ﹤0.01% 2925

Other funds holding SCMP

Nationwide Fund Advisors's SCMP Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q4 2017, closing a stake of 32,008 shares — an estimated $378K sold.

Nationwide Fund Advisors first reported a position in SCMP in Q2 2013 and held it in 18 quarters. The position peaked at $1.44M in Q4 2014. 188 funds tracked by Wall St. Rank hold SCMP as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 32,008 Sucampo Pharmaceuticals, Inc. shares in Q4 2017, an estimated $378K.
  • Nationwide Fund Advisors first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Sucampo Pharmaceuticals, Inc. position peaked at $1.44M in Q4 2014.
  • 188 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.